568 related articles for article (PubMed ID: 7504978)
61. [Germ cell testicular tumors. Three therapeutic periods].
Fargeot P
Bull Cancer; 1990; 77(4):331-9. PubMed ID: 1693863
[TBL] [Abstract][Full Text] [Related]
62. [Biological markers for tumours of the testis. Their use in diagnosis, prognosis and follow-up in 200 cases (author's transl)].
Bellet D; Caillaud JM; Droz JP; Delarue JC; Bohuon C
Nouv Presse Med; 1981 Nov; 10(40):3293-7. PubMed ID: 6170931
[TBL] [Abstract][Full Text] [Related]
63. [The diagnostic and prognostic value of tumor markers in nonseminomatous stage-III to -IV testicular tumors].
Sakalo VS; Klimenko IA; Iaremko VN; Zaparin VK
Urol Nefrol (Mosk); 1989; (3):42-6. PubMed ID: 2475955
[TBL] [Abstract][Full Text] [Related]
64. [Tumor marker diagnosis in non-seminomatous testicular tumors using human chorionic gonadotropin (HCG) and alpha fetoprotein (AFP)].
Boewer C; Nawka S; Fleck H; Uibel M; Immer U; Schmidt HE; Herzmann H; Pilgrim G; Ziegenbein R
Z Urol Nephrol; 1985 Feb; 78(2):77-86. PubMed ID: 2581393
[TBL] [Abstract][Full Text] [Related]
65. Prognostic factors for favorable outcome in disseminated germ cell tumors.
Birch R; Williams S; Cone A; Einhorn L; Roark P; Turner S; Greco FA
J Clin Oncol; 1986 Mar; 4(3):400-7. PubMed ID: 2419524
[TBL] [Abstract][Full Text] [Related]
66. The United Kingdom Children's Cancer Study Group's second germ cell tumor study: carboplatin, etoposide, and bleomycin are effective treatment for children with malignant extracranial germ cell tumors, with acceptable toxicity.
Mann JR; Raafat F; Robinson K; Imeson J; Gornall P; Sokal M; Gray E; McKeever P; Hale J; Bailey S; Oakhill A
J Clin Oncol; 2000 Nov; 18(22):3809-18. PubMed ID: 11078494
[TBL] [Abstract][Full Text] [Related]
67. Detection of recurrence in patients with clinical stage I nonseminomatous testicular germ cell tumors and consequences for further follow-up: a single-center 10-year experience.
Gels ME; Hoekstra HJ; Sleijfer DT; Marrink J; de Bruijn HW; Molenaar WM; Freling NJ; Droste JH; Schraffordt Koops H
J Clin Oncol; 1995 May; 13(5):1188-94. PubMed ID: 7537802
[TBL] [Abstract][Full Text] [Related]
68. Potential therapeutic and diagnostic applications of the growth of testicular cancer in soft agar.
Foster BJ; Javadpour N; Ozols RF
Int J Cell Cloning; 1983 Apr; 1(1):2-14. PubMed ID: 6201566
[TBL] [Abstract][Full Text] [Related]
69. Prognostic significance of early serum tumor marker half-life in metastatic testicular teratoma.
Stevens MJ; Norman AR; Dearnaley DP; Horwich A
J Clin Oncol; 1995 Jan; 13(1):87-92. PubMed ID: 7528272
[TBL] [Abstract][Full Text] [Related]
70. [Serum levels of alpha fetoprotein (AFP), B-chorionic gonadotropin (BHCG), ferritin and prostatic acid phosphatase (PAP) in patients with cancer of the stomach].
Bukowski J; Góźdź S; Słuszniak J; Słuszniak A; Korejba W; Zieliński A; Banasińska E
Wiad Lek; 1988 Jul; 41(14):915-20. PubMed ID: 2467444
[No Abstract] [Full Text] [Related]
71. [Tumor markers--personal experience. Multidisciplinary treatment of disseminated germ cell tumor in full use of tumor markers].
Tobisu K
Gan To Kagaku Ryoho; 1991 Jun; 18(7):1221-6. PubMed ID: 1711304
[TBL] [Abstract][Full Text] [Related]
72. [Clinical outcome of adult testicular tumor. II. Study on patients with positive human chorionic gonadotropin].
Sakuramoto T; Kihara K; Kawai T
Hinyokika Kiyo; 1984 May; 30(5):639-49. PubMed ID: 6089533
[TBL] [Abstract][Full Text] [Related]
73. [Clinical studies of testicular tumor. I. Analysis of 27 patients with seminoma: the clinical significance of hCG-beta determination and of retroperitoneal lymph node dissection for stage I patients].
Tsukamoto T; Kumamoto Y; Ohmura K; Tsunekawa T; Yamazaki K
Hinyokika Kiyo; 1986 Jul; 32(7):989-97. PubMed ID: 2430436
[TBL] [Abstract][Full Text] [Related]
74. [Clinical outcome of adult testicular tumor. I. Study on patients of nonseminoma with negative human chorionic gonadotropin].
Kawai T; Sakuramoto T; Kihara K
Hinyokika Kiyo; 1984 May; 30(5):627-37. PubMed ID: 6089532
[TBL] [Abstract][Full Text] [Related]
75. Significance of the 'maturation' of metastases from germ cell tumours after intensive chemotherapy.
McCartney AC; Paradinas FJ; Newlands ES
Histopathology; 1984 May; 8(3):457-67. PubMed ID: 6203825
[TBL] [Abstract][Full Text] [Related]
76. [Histopathology of testicular germ cell tumors].
Morinaga S; Sasano N
Gan To Kagaku Ryoho; 1984 Dec; 11(12 Pt 1):2460-7. PubMed ID: 6210048
[TBL] [Abstract][Full Text] [Related]
77. Prognostic factors in advanced non-seminomatous germ-cell testicular tumours: results of a multicentre study. Report from the Medical Research Council Working Party on Testicular Tumours.
Lancet; 1985 Jan; 1(8419):8-11. PubMed ID: 2578205
[TBL] [Abstract][Full Text] [Related]
78. Identification of prognostic subgroups among patients with metastatic 'IGCCCG poor-prognosis' germ-cell cancer: an explorative analysis using cart modeling.
Kollmannsberger C; Nichols C; Meisner C; Mayer F; Kanz L; Bokemeyer C
Ann Oncol; 2000 Sep; 11(9):1115-20. PubMed ID: 11061604
[TBL] [Abstract][Full Text] [Related]
79. Immunohistological localization of AFP and HCG in uniformly classified testis tumors.
Wittekind C; Wichmann T; Von Kleist S
Anticancer Res; 1983; 3(5):327-30. PubMed ID: 6197005
[TBL] [Abstract][Full Text] [Related]
80. Outcome of patients with stage II and III nonseminomatous germ cell tumors: results of a single center.
Ataergin S; Ozet A; Arpaci F; Kilic S; Beyzadeoglu M; Komurcu S
Indian J Cancer; 2007; 44(1):6-11. PubMed ID: 17401218
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]